There's little evidence that GLP-1 patches work at all, let alone better than clinically approved weight loss injections
When AOD-9604 activates these receptors in fat tissue, it triggers localized lipolytic responses without sending signals to the brains feeding centers
No matter if they come from our bodies or from the action of Candida in our gut, these aldehydes can easily become neurotoxins
GLP-1 medications may be worth discussing with your provider if you have PMOS and one or more of these patterns: Insulin resistance, prediabetes, type 2 diabetes, or elevated fasting insulin
while its antioxidants protect against free radical damage and slow age-related cognitive decline
Retatrutide: the triple agonist frontier Retatrutide represents the next evolution, a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously